The Medical Research Council (MRC) is shaking up its approach to sharing its groundbreaking work with the public. From next year, the MRC will focus on using compelling storytelling to illustrate the impact of its research funding, rather than relying solely on technical blogs and reports. This bold new direction aims to make medical science more accessible and engaging for everyone.
The MRC Insight blog, along with other UK Research and Innovation (UKRI) blogs, will be closing down as part of this change. But don't worry - all existing articles will remain available on the MRC website and LinkedIn channels. The council is committed to continuing to publish news stories, impact reports, and articles that showcase how MRC-funded research is transforming healthcare in the UK.
To make information more easily accessible, the MRC is introducing a new newsletter. This quarterly publication will provide updates from the Senior Executive Team, highlight upcoming opportunities for researchers, and offer insights into the latest developments in medical science. Subscribers will be among the first to receive this new resource, which promises to bring research news direct to their inbox.
At the heart of the MRC's approach is a commitment to showcasing the value of curiosity-driven discovery research through compelling narratives. The organisation acknowledges that breakthroughs often take time – sometimes decades – from initial discovery to widespread healthcare application. Drawing inspiration from experts like Sir David Attenborough, who has long made complex scientific concepts accessible to a wider audience, the MRC aims to humanise the world of medical science.
Recent advances demonstrate the tangible impact of this research. For example, decades of MRC investment in immunology and antibody research have led to the rollout of a new one-minute immunotherapy injection for cancer patients across the NHS. This innovation offers faster and more convenient treatment for tens of thousands of patients each year. The MRC has also played a crucial role in the success of the NHS Bowel Screening Programme, which has improved early detection and treatment outcomes for bowel cancer.